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San Francisco bus drivers have an increased prevalence of hypertension. This study examined
relationships between blood lead concentration and blood pressure in 342 drivers. The analysis
reported in this study was limited to subjects not on treatment for hypertension (n = 288). Systolic
and diastolic pressures varied from 102 to 173 mm Hg and from 61 to 105 mm Hg, respectively.
The blood lead concentration varied from 2 to 15 jig/dL The relationship between blood pressure
and the logarithm of blood lead concentration was examined using multiple regression analysis.
Covariates included age, body mass index, sex, race, and caffeine intake. The largest regression
coefficient relating systolic blood pressure and blood lead concentration was 1.8 mm Hg/ln (pg/dL)
[90% C. I., -1.6, 5.31. The coefficient for diastolic blood pressure was 2.5 mm Hg/ln (pg/dL) [90%
C. I., 0.1, 4.91. These findings suggest effects of lead exposure at lower blood lead concentrations
than those concentrations that have previously been linked with increases in blood pressure.
Introduction
An increased prevalence of cardiovascular disease,
including hypertension, has been noted in transit
worker populations (1-9). There has been a parallel
concern about lead exposure from vehicular exhaust
(10-13). The relationship between lead exposure and
blood pressure has been a recent focus of attention (14-
18). Both experimental and observational studies
corroborate a causal relationship between low-level lead
exposure and increased blood pressure (19); however,
this relationship has not been studied in transit
workers.
Unadjusted hypertension prevalences in San Fran-
cisco bus drivers were 47.4/100 for blacks and 40.2/100
for whites, using the criteria systolic pressure > 140
mm Hg or diastolic pressure > 90 mm Hg (9). Stra-
tifying on age and race, these rates were 1.3 to 1.9 times
greater than rates for males in the National Health and
Nutrition Examination Survey (NHANES) II study;
the Alameda County Hypertension Control Program
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study; and men undergoing pre-employment screen-
ing for bus driver positions (9).
Subjects and Methods
Drivers were approached at their biennial medical
examination; 342 of 456 agreed to participate. Three
blood pressure measurements were taken by mercury
sphygmomanometry (diastolic phase V). Differences
between the means of the first and second measure-
ments (designated as contrasts) and their 99% confi-
dence intervals for all subjects were -0.1 [-1.3, 1.01 mm
Hg for systolic blood pressure and 0.04 [-0.7, 0.81 mm
Hg for diastolic blood pressure. Contrasts between the
average of the first two measurements and the third
were 2.6 [1.5, 3.7] and 0.8 [0.1, 1.51 mm Hg, respectively.
These latter contrasts were small to moderate in
magnitude but statistically significant. Subsequently,
the average of the first two measurements (AVSYS12,
AVDIA12), the third measurement (SYS3, DIA3), and
the average of all three (AVESYS, AVEDIA) were used
as separate outcome indicators in examining the
relationship between blood pressure and blood lead
concentration. Additional data (age, race, sex, etc.) were
abstracted from the clinic record as well as a ques-SHARPETAL.
tionnaire designed specifically for this study.
From each participant, 10 mL of blood was drawn
directly into polypropylene tubes containing Li-hepa-
rin and frozen for later analysis. Blood lead concen-
trations were determined at the Toxicology Laboratory,
San Francisco General Hospital Medical Center, by
atomic absorption spectrophotometry (20). This lab-
oratory participates in the Centers for Disease Control
(CDC) interlaboratory standards control program for
lead analysis.
Two samples were analyzed from each specimen and
recorded if the absorbance values were within 10% of
each other. If the values were not within 10% a third
sample was analyzed, and the closest two absorbance
values were chosen. The mean absolute difference be-
tween the two samples was 0.51 ,ug/dL. Five percent of
these differences exceeded 1.34gg/dL.
Quality control checks using bovine blood standards
obtained from the CDC were performed after every sec-
ond to fifth specimen. The standard control value was
19.0 ,ug/dL. The mean and standard deviation of these
checks were 18.7 ± 1.28gg/dL (n = 122). Control values
determined within a given standards curve showed a
significant and continuous downward trend due to
the impact of degradation of the graphite furnace on
the absorbance signal. Each unknown specimen blood
lead concentration (PbB) was adjusted by- the quality
controls (QC1, QC2) bounding it by
PbBadj= PbB 19.0
L2(QC1+QC2)
Twenty-two external quality controls were incorpo-
rated into the specimen collection. The mean and
standard deviation ofthese were 4.2 ± 0.9 gg/dL.
Analysis of variance for unequal sample sizes and
multiple regression methods were used to assess rela-
tionships (21). Subjects treated for hypertension were
excluded. Precision of estimated parameters was
assessed using 90% confidence intervals. This level was
chosen because the blood lead concentration/blood
pressure relationship has already been established in a
number of population studies (14-18). Also, the lower
bound of the interval effectively functions as a 95% test
of statistical significance for the directional hypothesis
of a positive relationship. If the lower confidence limit
is greater than 0, then the one-tailed p value is < 0.05.
Bootstrap methods were used to validate the magni-
tude and precision of the estimated relationship be-
tween blood pressure and blood lead concentration in
selectedcases (22,23).
Results
Table 1 illustrates the age, race, sex, and body mass
index (BMI) characteristic of the study sample. Table 2
presents the univariate distributions of blood pressure
and blood lead concentration. The distribution of blood
lead concentration was remarkably low considering
Table 1. Descriptive statistics offeatures characterizing
the study sample.
Variable n Mean SD Range
Age, years
Males 261 42.7 7.13 30.6-64.7
Females 27 40.3 6.89 27.9-54.5
BMI,akg/M2
Males 259 27.2 4.30 18.6-45.3






aBMI, body mass index.
the subjects were city bus drivers. The range varied
from 2 to 15 jg/dL.
The age-adjusted mean and standard error, and
median for the average systolic (AVESYS) and
average diastolic (AVEDIA) blood pressures among
four ordered categories of blood lead concentration are
presented in Table 3. There was no apparent trend,
although for both systolic and diastolic blood pressure
the lowest average values were in the lowest quartile of
blood lead concentration.
Multiple regression analyses are presented in Tables
4 and 5. AVSYS12, AVDIA12; SYS3, DIA3; and
AVESYS, AVEDIA were used as dependent variables in
separate analyses. The logarithmic transformed blood
lead concentration was used in these models. The
justification for doing so has been to normalize the
blood lead concentration distribution. While the
logarithmic transformation appears to accomplish
this, it also imposes a nonlinear scale transformation
that may not bejustified. However, results are presented
in this manner for consistency with other published
studies (14,15).
Covariates included in the model were age, the
square of age, race, sex, body mass index nested in sex,
and frequency of caffeine consumption. There is evi-
dence that recent caffeine ingestion affects blood pres-
sure measurements (24).
Because multiple regression models are prone to bias
from outliers, the influence of each observation on the
magnitude of the regression coefficient relating blood
lead concentration and blood pressure was examined.
The magnitude of this influence is measurable by a
standardized parameter available in the PROC REG
procedure in SAS (21).
Single, but different, observations were identified as
outliers for systolic and diastolic measures. These
outliers produced values of the influence parameter
that were 6.47 and 6.99 standard deviations removed
from the mean influence value for SYS3 and
AVDIA12, respectively. The next set of most influential
points were 3.0 to 3.4 standard deviations from the
mean for all models involving the different blood
pressure variables as outcomes.
The effectofexcluding these observations is presented
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Table 2. Univariate distributions ofblood pressures and blood lead concentration in subjects not currently treated for hypertension.a
Percentiles
Measurement 1% 5% 10% 25% 50% 75% 90% 95% 99%
AVESYS,b mm Hg 102 107 109 115 123 132 141 148 173
AVEDIA,c mm Hg 61 67 70 75 81 85 91 95 105
PbB, pg/dL 2.3 3.6 3.9 4.8 6.4 8.1 9.4 10.8 15.5
aThe reader is cautioned not to relate variables within apercentile. n = 288.
bAVESYS, average systolic pressure.
CAVEDIA, average diastolic pressure.
Table 3. Distribution ofaverage systolic and diastolic blood pressures in four categories ofblood lead concentration.
PbB Mean Mean ± SE
Measurement quartile PbB, pg/dL n Mean ± SE age adj Median
AVESYS, mm Hg 1 4.0 ± 0.08 72 123.0 ± 1.58 123.3 ± 1.55 121.7
2 5.7 ± 0.05 72 125.7 ± 1.52 125.9 ± 1.54 125.3
3 7.2 ± 0.05 72 128.8 ± 1.77 126.0 ± 1.54 122.7
4 9.9 ± 0.26 72 124.8 ± 1.47 124.2 ± 1.55 122.7
AVEDIA, mm Hg 1 4.0 ± 0.08 72 79.0 ± 1.03 79.3 ± 1.04 80.0
2 5.7 ± 0.05 72 80.9 ± 0.96 81.0 ± 1.03 80.3
3 7.2 ± 0.05 72 82.0 ± 1.20 81.9 ± 1.03 81.3
4 9.9 ± 0.26 72 81.4 ± 0.94 81.2 ± 1.04 82.3





AVSYS12 SYS3 AVESYS 90% C. I. df
0.32 [-3.51, 4.161 276b
1.95 [-1.76, 5.651 276b
0.86 [-2.86, 4.581 276b
-0.34 [4.00, 3.321 265
1.07 [-2.46, 4.611 265
0.63 [-3.40, 3.66] 265
0.28 [-3.34, 3.891 264c
1.83 [-1.63,5.281 264c
0.79 [-2.68, 4.271 264c
aAdjusted for age, body mass index, sex, race, and caffeine intake.
bNo adjustment for any covariate.
COutlier removed.





AVDIA12 DIA3 AVEDIA 90% C. I. df
2.25 [-0.25, 4.74] 276b
1.79 [-0.68, 4.251 276b
2.09 [-0.34, 4.53] 276b
2.01 [-0.38, 4.391 265
1.49 [-0.87, 3.851 265
1.83 [-0.49, 4.161 265
2.60 [0.19, 5.011 264c
2.16 [-0.22, 4.541 264c
2.45 [0.10, 4.801 264c
aAdjusted for age, body mass index, sex, race, caffeine intake.
bNo adjustment for any covariate.
COutlier removed.
in the last section ofTables 4 and 5. The excluded obser-
vations were on a subject with a low blood lead concen-
tration and a high blood pressure in the case of the
systolic pressure, and on a subject with high blood lead
concentration but low blood pressure in the case of the
diastolic pressure. There was insufficient information
from clinic records to exclude the subjects on known
medical grounds, although the subject excluded from
models involving diastolic blood pressure had sickle
cell trait and a history of hypertension in both parents.
Upon examining systolic pressure (Table 4), the
largest adjusted regression coefficient appeared to be 1 to
2 mm Hg/ln(ug/dL), but so imprecisely estimated
[approximate 90%, C. I., -2.0, 5.01 as to suggest no
relationship. Table 5 presents the results for diastolic
blood pressure. The adjusted regression coefficient was
2.2 to 2.6 mm Hg/ln(jig/dL) [90%, C. I., 0.1, 4.91.
Figures 1 and 2 present distributions of regression
coefficients obtained by bootstrap simulations using
SYS3 and AVDIA12, respectively, as dependent varia-
bles. A bootstrap simulation is a cross-validation proce-
dure with two basic steps. First, subjects are randomly
picked from the study sample with replacement for a
total number equal to the sample size used in the model
of interest. Thus, some subjects may be chosen more
than once, and some not at all. The data from these
chosen subjects are used in the multiple regression
model of interest to generate estimates ofthe regression
coefficients.
Second, this procedure is repeated a set number of
times (e.g., 1000), with the coefficient(s) of interest
saved. The mean value of a particular coefficient and its
standard deviation are internally valid estimators of
the original sample's estimated regression coefficient
and standard error (22,23).
No subjects were excluded from the respective sam-
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FIGURE 1. Distribution of regression coefficients from a multiple regres-
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FIGURE 2. Distribution ofregression coefficients from a multiple regres-
sion model relating AVDIA12 to ln(PbB) using a bootstrap simula-
tion (1000 repetitions).
1.16 mm Hg/ln(gg/dL) was obtained for SYS3.
Twenty-seven percent ofthe coefficients were less than 0.
A mean coefficient of 2.03 mm Hg/ln(,ug/dL) was
obtained for AVDIA12. Six percent of the coefficients
were less than 0.
Discussion
The blood lead concentrations in these subjects were
quite low (median: 6.4 ,ug/dL, range: 2-15 ,ug/dL).
This contrasts with the higher ranges reported in the
National Health and Nutrition Examination Survey
(NHANES) II study of 8 to 35 gg/dL (15), and a
similar, though slightly lower, range in the British
Regional Heart (BRH) Study (17).
In spite of these low values, evidence for an inde-
pendent relationship between blood pressure and blood
lead concentration was found. This relationship was
most apparent with diastolic blood pressure [2-3 mm
Hg/ln(,ug/dL), 90% C.I.: [0.1, 4.9)], but uncertain with
systolic blood pressure [1-2 mm Hg/ln(,ug/dL),
approximate 90% C. I., -2.0, 5.0].
The regression coefficient predicting diastolic blood
pressure was comparable to those reported for the
NHANES II and BRH Studies. Reanalysis of these data
by the Environmental Protection Agency (25) and
Pocock et al. (26) yielded coefficients of 1.4 to 2.7 mm
Hg/ln(,ug/dL) for NHANES II, and 1.8 mm Hg/ln
(,ug/dL) for the BRH Study.
It is unclear whether alcohol consumption should be
included as a covariate in these models relating blood
pressure and blood lead concentration. There is evi-
dence that alcohol consumption is associated with ele-
vated blood pressure (27). However, it is not clear
whether this association is directly causal (28);
whether it is indirectly causal, being mediated by
some impact on increased lead activity (29-32); or
whether it reflects lead contamination of alcoholic
beverages (33,34). Adjusting for alcohol consumption
could result in undesirable overcontrol of lead ex-
posure.
The impact of including a variable for alcohol
consumption derived from questionnaire data (grams
of ethanol per week) on the regression coefficients
relating systolic and diastolic blood pressure, and blood
lead concentration is a reduction of approximately 0.3
mm Hg/ln(,ug/dL) in the magnitudes of the coef-
ficient. It is not clear what such a change in the
regression coefficient means. It may be that the
unadjusted relationship is confounded by alcohol
consumption, and thus inclusion of a measure of
alcohol intake adjusts for this confounding. However,
it may be that alcohol intake acts as an indirect
indicator of a lead effect on blood pressure, and thus
inclusion of this variable in the regression model acts
to overcontrol for lead activity in its relationship with
blood pressure. Indeed, it is possible that both processes
are operable. Resolution of this dilemma rests with a
better understanding of the biological relationships
among lead, alcohol, and blood pressure.
Mechanisms
Most lead in the body is stored in the bone. Bone
deposition effectively sequesters lead from susceptible
organs. However, this depository, upon resorption, also
acts as a source of internal exposure to these same
organs.
Bone resorption is under the control of parathyroid
hormone (PTH). Thus, PTH activity may be a deter-
minant in the equilibrium between bone and soft
tissue lead concentration. Serum PTH concentrations
and chelated urinary lead excretion have been shown
to be increased in hypertensive patients with gouty
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nephropathy when compared to age-matched controls
with glomerulonephritis (35). An unselected popula-
tion is not readily comparable to the patients in this
clinical study; however, these findings, coupled with
established knowledge that chronic, low-level lead
exposure is related to blood pressure and indicators of
calcium metabolism and that lead sequestered in the
kidney affects renal tubule reabsorption of calcium (36)
and phosphate (37), suggest that effects on parathyroid
hormone metabolism may be relevant to people
without overt clinical disease.
The causal relationship between hypertension and
renal failure is not readily apparent. Lead accumu-
lation appears to play a role in both conditions (38).
One scenario suggests that chronic lead accumulation
causes hypertension, and hypertension leads to renal
failure. A contrasting scenario suggests lead accumu-
lation in the kidney leads to subclinical renal dys-
function, which in turn causes hypertension. It is
conceivable that both scenarios interact in a positive
feedback mechanism, leading to progressive hyper-
tensive disease and renal failure. Chronic lead accum-
ulation, internal lead mobilization from bone resorp-
tion by the action of PTH, and lead-induced alterna-
tions in kidney tubule reabsorption of electrolytes
affecting PTH elaboration are interactive factors
requiring further investigation.
Reliability Issues
There are three aspects to reliability in lead/hyper-
tension research. The first is how reliable the opera-
tional indicators of lead accumulation and blood
pressure status reflect the underlying biological pro-
cesses. The second is how reliably the given operational
indicators are actually measured by the study design.
The third relates to the reliability of the laboratory
analysis procedure.
Single cross-sectional blood lead concentration and
blood pressure measurements are indirect indicators
of the true effect of chronic lead accumulation on car-
diovascular function, and relate weakly to actual lead
activity and pathophysiologic effect. Given that the
operational indicators of blood pressure status and lead
accumulation are truly related, then the public health
importance of this relationship is probably much
greater than suggested by published studies (19). The
unreliability of these measures (single blood pressure
measurements and blood lead concentrations) in
reflecting the underlying biological process is not ad-
dressed by improving measurement precision. This
can be resolved only by more specific tools of measure-
ment.
The second aspect of reliability relates to measure-
ment precision. Single measurements are relatively
imprecise indicators of steady-state blood lead concen-
tration and blood pressure status. Individual blood
lead concentrations can vary over a period ofweeks due
to changing environmental exposures. A similar
problem exists with blood pressure measurement,
which is affected by endogenous catecholamines and
by proximate caffeine and nicotine consumption. The
question arises whether, and under what conditions,
this second reliability problem is important.
In cross-sectional studies the magnitude of a rela-
tionship (either a correlation or a regression coeffi-
cient) can be biased to zero if the measurement vari-
ables are unreliable. The magnitude of this bias
depends on the ratio of the within-subjects variance to
the between-subjects variance (39). This issue has been
particularly important in nutritional studies (40-44).
The ratio has been reported to be as high as 10 to 20,
although it is usually 0.3 to 4 (41).
The biasing effect of this ratio is given for the
correlation coefficient by
PDF[ (a 2 2 ,|1 PDF4(i1+ W O 2]
where PDF is the estimated population correlation coef-
ficient; pxy is the true value, a2 and c2 are the within-
subjects and between-subjects variances for the variable
X, 42 and 2 are the respective variances for the
variable y; and n1 and n2 are the number of repeated
measurements of x and y for each subject. Reliability is
improved by increasing the number of measurements
within a subject, not by increasing the number of
subjects.
Reliability bias can be examined in this study of bus
drivers by estimating the variance ratios for blood
pressure and blood lead concentration. An inexact
estimate of the within-subject variation is obtained for
blood pressure from the three measures taken during
the examination. The variance ratios are 0.12 for both
systolic and diastolic pressures. An observed correla-
tion coefficient involving either measure would be
biased low by about 2% from this source of variation.
However, other sources of variation (e.g., day-to-day,
etc.) could be much larger, and thus bias the relation-
ship substantially more.
Unreliability in the blood lead concentration mea-
surement cannot be assessed directly from the data on
bus drivers. It can be approximated using the data of
Cope et al. (45). Up to seven repeated measurements of
blood lead concentration over a period of 3 months
were made in five refinery workers exposed to alkyl
and inorganic lead. The average within-subjects var-
iance derived from this data is 0.01 1n2 (,ug/dL). The
interindividual variance from the bus driver study is
0.14 1n2 (,ug/dL). The variance ratio of 0.07 would
result in a bias of about -3.0%.
The combined impact of unreliability in both
variables from these approximations would be about
-5.0%. Although this bias appears to be minor, without
direct assessment of within-subjects variation in the
context of a specific study design, it could be much
larger.
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The third reliability issue relates to laboratory
analysis. Blood lead concentration measurements are
notoriously subject to bias from contamination. Im-
precision problems can be manifest when the blood lead
concentrations within a study group are low and
limited in range. Demonstration of a relationship
between blood pressure and blood lead concentration in
this study depended intimately on laboratory tech-
niques that enhanced precision and compensated for
internal biases. Future work that involves such low
blood lead concentrations must document the preci-
sion of the analytic technique, especially in studies that
fail to demonstrate relationships.
Conclusions
Sizable proportions of the population are exposed to
low levels of lead and develop hypertension. Even
though the relationship between blood lead concen-
tration and blood pressure appears to be weak, the effect
attributable to lead exposure may be substantial due to
the magnitude of these proportions.
It is unclear whether a reduction in lead accumu-
lation in the adult hypertensive population would
result in a substantial decrease in hypertension. The
blood pressure elevation attributable to lead exposure
could effectively be irreversible given that the toxi-
cokinetics of lead distribution limit lead excretion
from the body and/or damage to organ systems
resulting in hypertension is irreparable. [Lead effects
on kidney function, which may play a role in lead-
related hypertension, appear to be reversible after
chelation therapy (46).] However, a reduction in lead
exposure in major segments of the population who
have yet to accumulate lead (i.e., children) would have
a substantial impact in reducing hypertensive disease
in the adult population of tomorrow.
This study of adult bus drivers demonstrates
relationships between blood lead concentration and
blood pressure at the lowest blood lead concentrations
reported to date. Deleterious effects on cognitive
development associated with similar blood lead con-
centration levels have recently been reported in child-
ren (47). Findings such as these in both adults and
children at exceedingly low levels of lead exposure
suggest a need to reassess whatconstitutes an acceptable
level of exposure in the population.
This project was partially supported by a Doctoral Student Support
Award for Research from the School of Public Health, University of
California, Berkeley, CA. D. S. Sharp was supported by a fellowship
from the University of California Toxic Substances Research and
Teaching Program.
REFERENCES
1. Berg, K. J., and Melkild, A. Coronary disease in a group of
Norwegian tram drivers. Acta Med. Scand. 171: 671-677 (1962).
2. Morris, J. N., Kagan, A., Pattison, D. C., Gardner, M. J., and Raffle,
P. A. B. Incidence and prediction of ischaemic heart-disease in
London busmen. Lancet ii: 553-559 (1966).
3. Rusconi, C., Arosio, G., Orlando, G., Petroboni, V., Riva, S., Gola,
E., Benedini, G., Cicogna, R., Frau, G., Prandini, B. D., Spandrio,
L., and Feroldi, P. Fattori di rischio coronarico e cardiopatia
ischemica nei conduttori e nei bigliettari di autobus. Minerva
Cardioangiol. 23: 718-727 (1975).
4. Netterstrom, B., and Laursen, P. Incidence and prevalence of
ischaemic heart disease among urban busdrivers in Copenhagen.
Scand. J. Soc. Med. 9: 75-79 (1981).
5. Backman, A. L. Health survey of professional drivers. Scand. J.
Work Environ. Health 9: 30-35 (1983).
6. Hartvig, P., and Midttun, 0. Coronary heart disease risk factors in
bus and truck drivers. Int. Arch. Occup. Environ. Health 52:
353-360 (1983).
7. Donskaya, L V., Badkhen, V. V., and Dubinina, I. A. Physiological
responses during work in machine operators with disturbances in
homeostasis (Russian). Fiziol. Chel. 10: 81-85 (1984).
8. Syme, S. L. Social determinants of health and disease. In: Maxcy-
Rosenau: Public Health and Preventive Medicine, 12th ed. U. M.
Last, Ed.), Appleton Century Crofts, NewYork, 1985, pp. 953-970.
9. Ragland, D. R., Winkleby, M., Schwalbe, J., Holman, B. L., Morse,
L., Syme, S. L., and Fisher, J. M. Prevalence of hypertension in bus
drivers. Int. J. Epidemiol. 16: 208-214 (1987).
10. The Working Group on Lead Contamination. Survey of lead in the
atmosphere ofthree urban communities. In: Environmental Health
Series, Public Health Service Publication No. 999-AP-12, U.S.
Department of Health, Education and Welfare, Washington, DC,
1965.
11. Jones, R. D., Commins, B. T., and Cernik, A. A. Blood lead and
carboxyhaemoglobin levels in London taxi drivers. Lancet ii:
302-303 (1972).
12. Boudene, C., Arsac, F., and Meininger, J. Etude des taux de plomb
dans l'air et dans la population en France. Arhiv. Hig. Rad. Toks.
26(suppl): 179-189 (1975).
13. Flindt, M. L. H., King, E., and Walsh, D. B. Blood lead and
erythrocyte deltaaminolevulinic acid dehydratase levels in
Manchester taxi drivers. Br. J. Ind. Med. 33: 79-84 (1976).
14. Pirkle, J. L., Schwartz, J., Landis, J. R., and Harlan, W. R. The
relationship between blood lead levels and blood pressure and its
cardiovascular risk implications. Am. J. Epidemiol. 121: 246-258
(1985).
15. Harlan, W. R., Landis, J. R., Schmouder, R. L., Goldstein, N. G., and
Harlan, L. C. Blood lead and blood pressure relationship in the
adolescent and adult US population. JAMA 253: 530-534 (1985).
16. Weiss, S. T., Munoz, A., Stein, A., Sparrow, D., and Speizer, F. E.
The relationship of blood lead to blood pressure in a longitudinal
study ofworking men. Am.J. Epidemiol. 123: 800-808 (1986).
17. Pocock, S. J., Saper, A. G., Ashby, D., Delves, T., and Whitehead, T.
P. Blood lead concentration, blood pressure, and renal function.
Br. Med.J. 289: 872-874 (1984).
18. Moreau, T., Orssaud, G., Juguet, B., and Busquet, G. Lettre-a-
l'editeur: Plombemie et pression arterielle: premiers resultats
d'une enquete transversale de 431 sujet de sexe masculin. Rev.
Epidemiol. Sante Publique 30: 395-397 (1982).
19. Sharp, D. S., Becker, C. E., and Smith, A. H. Chronic low-level lead
exposure. Its role in the pathogenesis of hypertension. Med.
Toxicol. 2: 210-232 (1987).
20. National Institute of Occupational Safety and Health. Analytical
Methods, Vol. 1, DHEW 77157-A, U.S. Public Health Service,
Washington, DC, 1977, p. 102.
21. SAS Institute, Inc. SAS User's Guide: Statistics, Version 5 ed. SAS
Institute, Inc., Cary, NC, 1985.
22. Efron, B. Thejackknife, the bootstrap and other resampling plans.
Society for Industrial and Applied Mathematics, Monograph no.
38, Philadelphia, 1982.
23. Efron, B., and Gong, G. A leisurely look at the bootstrap, and the
jackknife, and cross-validation. Am. Stat. 37: 36-48 (1983).
24. Fredholm, B. B. Cardiovascular and renal actions of methyl-
xanthines. In: The Methylxanthine Beverages and Foods: Chem-
istry, Consumption, and Health Effects (G. A. Spiller, Ed.), Alan R.
Liss, Inc., NewYork, 1984, pp. 303-330.
25. Environmental Criteria and Assessment Office. Lead effects-onBLOOD PRESSUREAND BLOOD LEAD INBUS DRIVERS 137
cardiovascular function, early development, and stature: An
addendum to U.S. EPA Air Quality Criteria for Lead. U.S.
Environmental Protection Agency, Research Triangle Park, NC,
1986.
26. Pocock, S. J., Shaper, A G., Ashby, D., and Delves, T. Blood lead
and blood pressure in middle-aged men. International Conference
on Heavy Metals in the Environment 1: 303-305 (1985).
27. MacMahon, S. W., and Norton, R. N. Alcohol and hypertension:
Implications for prevention and treatment. Ann. Intern. Med. 105:
124-125 (1986).
28. Friedman, G. D., Klatsky, A. L., and Siegelaub, A. B. Alcohol intake
and hypertension. Ann. Intern. Med. 98(2): 846-849 (1983).
29. Bortoli, A., Mattiello, G., Zotti, S., Bonvicini, P., Trabuio, G., and
Fazzin, G. Blood-lead levels in patients with chronic liver diseases.
Int. Arch. Occup. Environ. Health 52: 49-57 (1983).
30. Magid, E., and Hilden, M. Elevated levels ofblood lead in alcoholic
liver disease. Int. Arch. Occup. Health 35: 61-65 (1975).
31. Grasmick, C., Huel, G., Moreau, T., and Sarmini, H. The combined
effect of tobacco and alcohol consumption on the level of lead and
cadmium in blood. Sci. Total Environ. 41: 207-217 (1985).
32. Dally, S., Danan, M., Buisine, A., Hispard, E., Girre, C., and
Fournier, P. E. Elevation de la plombemie au cours de l'alcoolisme:
Relation avec la pression arterielle. Presse Med. 15: 1227-1229
(1986).
33. Olsen, N. B., Hollnagel, H., and Grandjean, P. Indicators of lead
exposure in an adult Danish suburban population. Dan. Med. Bull.
28: 168-176 (1981).
34. Grandjean, P., Olsen, N. B., and Hollnagel, H. Influence of
smoking and alcohol consumption on blood lead levels. Int. Arch.
Occup. Environ. Health 48: 391-397 (1981).
35. Colleoni, N., and D'Amico, G. Chronic lead accumulation as a
possible cause of renal failure in gouty patients. Nephron 44:
32-35 (1986).
36. Victery,W., Miller, C. R., Zhu, S., and Goyer, R. A. Effect ofdifferent
levels and periods of lead exposure on tissue levels and excretion
of lead, zinc, and calcium in the rat. Fundam. Appl. Toxicol. 8:
506-516 (1987).
37. Hammond, P. B., and Beliles, R. P. Metals. In: Casarett and Doull's
Toxicology: The Basic Science of Poisons, 2nd ed. J. Doull, C. D.
Klaassen, and M. 0. Amdur, Eds.), Macmillan, NewYork, 1980, pp.
418-419.
38. Batuman, V., Landy, E., Masaka, J. K., and Wedeen, R. P.
Contribution of lead to hypertension with renal impairment. N.
Engl. J. Med. 309: 17-21 (1983).
39. Fleiss, J. L. The Design and Analysis of Clinical Experiments.
Wiley, NewYork, 1986, pp. 1-32.
40. Liu, K., Stamler, J., Dyer, A., McKeever, J., and McKeever, P.
Statistical methods to assess and minimize the role of intra-
individual variability in obscuring the relationship between dietary
lipids and serum cholesterol. J. Chron. Dis. 31: 399-418 (1978).
41. Sempos, C. T., Johnson, N. E., Smith, E. L., and Gilligan, C. Effects
of intraindividual and interindividual variation in repeated dietary
records. Am.J. Epidemiol. 121: 120-130 (1985).
42. Jacobs, D. R., Anderson, J. T., and Blackburn, H. Diet and serum
cholesterol: Do zero correlations negate the relationship? Am. J.
Epidemiol. 110: 77-87 (1979).
43. Beaton, G. H., Milner, J., Corey, P., McGuire, V., Cousins, M.,
Stewart, E., de Ramos, M., Hewitt, D., Grambsch, P. V., Kassim, N.
and Little, J. A. Sources of variance in 24-hour dietary recall data:
Implications for nutrition study design and interpretation. Am. J.
Clin. Nutr. 32: 2546-2559 (1979).
44. Beaton, G. H., Milner, J., McGuire,V., Feather,T. E., and Little, J. A.
Source of variance in 24-hour dietary recall data: Implications for
nutrition study design and interpretation. Carbohydrate sources,
vitamins, and minerals. Am. J. Clin. Nutr. 37: 986-995 (1983).
45. Cope, R F., Pancamo, B. P., Rinehart, W. E., and Ter Haar, G. L.
Personnel monitoring for tetraalkyl lead in the workplace. Am. Ind.
Hyg. Assoc. J. 40: 372-379 (1979).
46. Wedeen, W. P., Mallik, D. K., and Batuman, V. Detection and
treatment ofoccupational lead nephropathy. Arch. Intern. Med. 139:
53-57 (1977).
47. Bellinger, D., Leviton, A., Waternaux, C., Needleman, H., and
Rabinowitz, M. Longitudinal analyses of prenatal and postnatal lead
exposure and early cognitive development. N. Engl. J. Med. 316:
1037-1043 (1987).